Senjuti Saha | |
|---|---|
Saha in 2026 | |
| Born | |
| Education | University of Toronto |
| Known for | Genome sequencing of SARS-CoV2 in Bangladesh |
| Awards | Full list |
| Scientific career | |
| Fields | Molecular genetics, microbiology, epidemiology |
| Workplaces | Child Health Research Foundation (CHRF) |
Senjuti Saha is a Bangladeshi scientist, serving as the Deputy Executive Director at the Child Health Research Foundation (CHRF). Her research focuses on infectious diseases, genomic epidemiology, antimicrobial resistance, and public health in low-resource settings. Currently, she directs multiple comprehensive studies, including projects on respiratory syncytial virus (RSV) infections, single-cell genomics, neonatal sepsis, and genomics for tackling antimicrobial resistance. Her research not only addresses the needs of low-resource settings but also informs global health strategies. Dr. Saha also founded and leads Building Scientists for Bangladesh, a country-wide initiative that reflects her commitment to building scientific capacity and promoting trust in science.
Saha was raised in Dhaka, Bangladesh. Her father Dr. Samir Kumar Saha is a microbiologist and her mother Dr. Setarunnahar Setara is a public health researcher. Senjuti Saha finished high school in Bangladesh. After her A-Levels, she completed her Bachelor of Science degree in biochemistry at the University of Toronto. She then received her PhD from the same institute.
Senjuti Saha started her career as a post-doctoral research fellow at The Hospital for Sick Children, Canada and Stanford University, USA. She was also appointed as a post-doctoral researcher at the Child Health Research Foundation (CHRF) in Bangladesh. In 2019, she joined CHRF as scientist. Currently, she is serving as the Deputy Executive Director at CHRF.
Saha returned to Bangladesh to work on the frontlines of public health and establish a state-of-the-art genomics center. Her groundbreaking work has advanced genomic epidemiology and antimicrobial resistance (AMR) research, with notable contributions to understanding resistance patterns in typhoid, paratyphoid, and Klebsiella infections.
In 2020, Senjuti Saha and her team decoded the genome sequence of SARS-CoV2 in Bangladesh. Prior to that, she had performed an unbiased metagenomic sequence analysis to show a correlation between pediatric meningitis and Chikungunya virus outbreak in Bangladesh.
Her studies generated critical evidence that facilitated the introduction of the typhoid conjugate vaccine (TCV) in Bangladesh in 2025.
Full Publication list